Expert in outcomes and evidence, Richard Willke, talks through early-stage economic modeling using pharmacokinetic/ pharmacodynamic (PK/PD) data sets; detailing what has been achieved so far and what further potential it holds.
Most Recent Flipbooks
Parexel expert Michelle Pietzak, MD reviews current findings and offers practical recommendations for gastrointestinal symptoms of COVID-19 and considerations for clinical trials.
In this article, experts from the Parexel Pediatric Collaborative Group review current findings and consider how sponsors can adapt their studies to changing conditions during COVID19.
This lay summary discusses what the guidance means for anyone in the USA who may be involved in or associated with a clinical trial.
In this article, Dr. Lazar Mandinov, Sr. Medical Director at Parexel, provides practical guidance for conducting CV clinical trials related to COVID-19.
Updated every day, in a single source
If regulatory and payer landscapes are so different, then why bring the two worlds together?
Parexel offers a complimentary, educational workshop custom built to your evidence and market access needs.